PEAK6 Investments’s Novavax NVAX Stock Holding History

PEAK6 Investments’s Portfolio NVAX Stock Details NVAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-40,700	Closed	-$282K	–	4450
2023 Q1	$282K	Buy	40,700 +15,600	+62%	+$144K	﹤0.01%	2853
2022 Q4	$258K	Sell	25,100 -182,300	-88%	-$3.22M	﹤0.01%	3094
2022 Q3	$3.77M	Buy	207,400 +82,000	+65%	+$3.55M	0.02%	1029
2022 Q2	$6.45M	Sell	125,400 -34,400	-22%	-$1.78M	0.01%	1181
2022 Q1	$11.8M	Sell	159,800 -245,800	-61%	-$21.9M	0.03%	623
2021 Q4	$58M	Buy	405,600 +216,100	+114%	+$37.1M	0.12%	152
2021 Q3	$39.3M	Sell	189,500 -140,700	-43%	-$31M	0.09%	193
2021 Q2	$70.1M	Buy	+330,200	New	+$60.5M	0.17%	101

Other funds holding NVAX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SCM

Shah Capital Management Raleigh, North Carolina $521M AUM 46.95% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

PEAK6 Investments's NVAX Position: Q3 2024 in Review

PEAK6 Investments increased its Novavax (NVAX) stake by 27% in Q3 2024, buying an estimated $62.5K and bringing the position to 23,000 shares worth $290K. The position accounts for ﹤0.01% of the portfolio, ranked #2609.

PEAK6 Investments first reported a position in NVAX in Q2 2021 and has held it in 10 quarters since. The position peaked at $11.8M in Q3 2021. 238 funds tracked by Wall St. Rank hold NVAX as of Q3 2024.

PEAK6 Investments held 23,000 shares of Novavax worth $290K as of Q3 2024.
PEAK6 Investments bought 4,837 Novavax shares in Q3 2024, an estimated $62.5K.
Novavax made up ﹤0.01% of PEAK6 Investments's portfolio in Q3 2024, its #2609 holding.
PEAK6 Investments first reported a position in Novavax in Q2 2021 and has held it in 10 quarters since.
PEAK6 Investments's Novavax position peaked at $11.8M in Q3 2021.
238 funds tracked by Wall St. Rank held Novavax as of Q3 2024.

Based on PEAK6 Investments's 13F filing for Q3 2024, filed 14 Nov 2024.